Expanded Access Use of Ladiratuzumab Vedotin in Advanced Solid Tumors
The purpose of this study is to provide the option of Ladiratuzumab Vedotin treatment to eligible patients in studies SGNLVA-005.
DRUG: ladiratuzumab vedotin
The purpose of this study is to provide the option of Ladiratuzumab Vedotin treatment to eligible patients in studies SGNLVA-005.